Ironwood Pharmaceuticals (IRWD) Deferred Taxes (2021 - 2026)

Ironwood Pharmaceuticals (IRWD) has 6 years of Deferred Taxes data on file, last reported at $19.2 million in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes rose 2765.07% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $59.3 million (down 5.39% YoY), and the FY2025 full-year result was $40.8 million, down 40.08% from the prior year.
• Deferred Taxes rose to $19.2 million in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $41.1 million in Q4 2024 to a low of -$1.7 million in Q4 2025.
• A 5-year average of $15.7 million and a median of $14.7 million in 2022 frame the typical range for Deferred Taxes.
• Across the five-year window, Deferred Taxes tumbled 104.25% in 2025 and surged 2765.07% in 2026, its largest moves.
• Tracing IRWD's Deferred Taxes over 5 years: stood at $20.1 million in 2022, then jumped by 55.6% to $31.3 million in 2023, then jumped by 31.23% to $41.1 million in 2024, then tumbled by 104.25% to -$1.7 million in 2025, then surged by 1199.43% to $19.2 million in 2026.
• Business Quant data shows IRWD's Deferred Taxes at $19.2 million in Q1 2026, -$1.7 million in Q4 2025, and $27.8 million in Q3 2025.